Tolerability and safety of anti-fibrotic agents for idiopathic pulmonary fibrosis in real world

被引：0
|
作者：
Sugimoto, Chikatoshi
Inoue, Yoshikazu
Arai, Toru
Kasai, Takehiko
Akira, Masanori
Hayashi, Seiji
Tachibana, Kazunobu
Sasaki, Yumiko
Takeuchi, Naoko
Minomo, Syojiro
Ikegami, Naoya
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 50卷
关键词：
D O I：
10.1183/1393003.congress-2017.PA4878
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4878
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-World Tolerability Of Anti-Fibrotic Therapy For Idiopathic Pulmonary Fibrosis
    Kaur, R.
    King, C.
    Brown, A.
    Shlobin, O.
    Ahmad, S.
    Weir, N.
    Nathan, S. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [2] The efficacy of anti-fibrotic agents for acute exacerbation of idiopathic pulmonary fibrosis
    Matsumoto, Yoko
    Furukawa, Ryutaro
    Ohara, Sayaka
    Usui, Kazuhiro
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [3] Medication Persistence Rates and Factors of Anti-Fibrotic Agents for Idiopathic Pulmonary Fibrosis: A Real-World Observational Study
    Oishi, K.
    Hirano, T.
    Hamada, K.
    Uehara, S.
    Suetake, R.
    Yamaji, Y.
    Asami, M.
    Edakuni, N.
    Matsumoto, T.
    Yano, M.
    Matsunaga, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [4] Real-world study evaluating anti-fibrotic therapy on survival in idiopathic pulmonary fibrosis
    Robertson, Lucy
    Barnes, Joshua
    Rogers, Kirstie
    Thillai, Muhunthan
    Parfrey, Helen
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [5] Real-life survival of idiopathic pulmonary fibrosis with anti-fibrotic medication
    Bleinc, Alexandre
    Blin, Timothee
    Legue, Sylvie
    Mankikian, Julie
    Plantier, Laurent
    Marchand-Adam, Sylvain
    REVUE DES MALADIES RESPIRATOIRES, 2023, 40 (05) : 371 - 381
  • [6] Tolerability and efficacy of switching anti-fibrotic treatment from nintedanib to pirfenidone for idiopathic pulmonary fibrosis
    Sugino, Keishi
    Ono, Hirotaka
    Saito, Mikako
    Ando, Masahiro
    Tsuboi, Eiyasu
    PLOS ONE, 2024, 19 (06):
  • [7] Clinico-radiological features and efficacy of anti-fibrotic agents in atypical idiopathic pulmonary fibrosis
    Sugino, Keishi
    Shimizu, Hiroshige
    Nakamura, Yasuhiko
    Isshiki, Takuma
    Matsumoto, Keiko
    Homma, Sakae
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 899 - 908
  • [8] REAL-WORLD MULTICENTER PROSPECTIVE STUDY OF COMBINATION THERAPY OF ANTI-FIBROTIC AGENTS IN IDIOPATHIC PULMONARY FIBROSIS (J-AVENGERS): INTERIM ANALYSIS
    Inomata, Minoru
    Kuse, Naoyuki
    Awano, Nobuyasu
    Sakamoto, Keita
    Fujimoto, Kazushi
    Muto, Yutaka
    Ito, Yu
    Chin, Haruka
    Umezawa, Hiroki
    Tanaka, Kensuke
    Nakamura, Yasuhiko
    Isshiki, Takuma
    Kishi, Kazuma
    Izumo, Takehiro
    CHEST, 2023, 164 (04) : 3039A - 3040A
  • [9] DISEASE PROGRESSION IN IDIOPATHIC PULMONARY FIBROSIS UNDER ANTI-FIBROTIC TREATMENT
    Cilli, Aykut
    Uzer, Fatih
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2023, 40 (03)
  • [10] Anti-Fibrotic Therapy and Patient Reported Outcomes in Idiopathic Pulmonary Fibrosis
    Kay, S.
    White, E. S.
    Sheth, J. S.
    Flaherty, C.
    Getty, C.
    Holtze, C.
    Wang, B.
    Salisbury, M.
    Belloli, E.
    Flaherty, K. R.
    Murray, S.
    Xia, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
12345